REQUEST A DEMO
Total
USD $0.00
Search more companies

Dr. Megyesi Pharma Kft. (Hungary)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: DR.MEGYESI PHARMA Kereskedelmi es Szolgaltato Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

DR.MEGYESI PHARMA Kereskedelmi es Szolgaltato Kft is a veterinary pharmaceutical company that distributes Veyx - Pharma products. They offer a range of injection solutions and preparations for the treatment of various diseases in horses, sheep, dogs, and cats, as well as supplements for metabolic and reproductive disorders in animals.

Headquarters
Nagytetenyi ut 222.
Budapest; Budapest; Postal Code: 1225

Contact Details: Purchase the Dr. Megyesi Pharma Kft. report to view the information.

Website: http://www.veyx.hu

Basic Information
Total Employees:
Purchase the Dr. Megyesi Pharma Kft. report to view the information.
Outstanding Shares:
Purchase the Dr. Megyesi Pharma Kft. report to view the information.
Registered Capital:
Purchase the Dr. Megyesi Pharma Kft. report to view the information.
Incorporation Date:
June 12, 2015
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
DIAPOLO SPORT Kereskedelmi es Szolgaltato Kft.
Company Performance
Financial values in the chart are available after Dr. Megyesi Pharma Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
-42.07%
Total operating revenue
-35.89%
Operating profit (EBIT)
-88.7%
EBITDA
-70.38%
Net Profit (Loss) for the Period
-86.59%
Total assets
-21.87%
Total equity
2.45%
Operating Profit Margin (ROS)
-7.89%
Net Profit Margin
-6.7%
Return on Equity (ROE)
-15.84%
Quick Ratio
0.21%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?